Rial, N. S., Zell, J. A., Cohen, A. M., & Gerner, E. W. (2012). Clinical endpoints for developing pharmaceuticals to manage patients with sporadic or genetic risk of colorectal cancer.
Chicago Style aipamenaRial, Nathaniel S., Jason A. Zell, Alfred M. Cohen, and Eugene W. Gerner. Clinical Endpoints for Developing Pharmaceuticals to Manage Patients With Sporadic or Genetic Risk of Colorectal Cancer. 2012.
MLA aipamenaRial, Nathaniel S., Jason A. Zell, Alfred M. Cohen, and Eugene W. Gerner. Clinical Endpoints for Developing Pharmaceuticals to Manage Patients With Sporadic or Genetic Risk of Colorectal Cancer. 2012.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.